Clinical trial No longer in our active list Phase 2 Interventional Ages 18 to 75

Evaluating VX-993 for pain relief after bunion surgery

Official title: A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Evaluating the Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy

Run by Vertex Pharmaceuticals Incorporated · NCT06619847 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new pain relief medication called VX-993 for people who have just had bunion surgery to see if it works better than a common painkiller.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment355 (estimated)
SponsorVertex Pharmaceuticals Incorporated
Industry-sponsored
Locations14 sites (Sheffield, Alabama and 13 other locations)
Trial IDNCT06619847 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals scheduled for a primary unilateral bunionectomy under regional anesthesia.

Probably not a fit

Patients with a history of bunionectomy on the same foot or those with significant medical complications during surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the efficacy, safety, tolerability, and pharmacokinetics of VX-993 in patients experiencing acute pain following a bunionectomy. Participants will receive either VX-993, a combination of hydrocodone and acetaminophen (HB/APAP), or a placebo. The study will monitor participants before and after surgery to ensure they meet specific inclusion criteria and to evaluate their pain management outcomes. The approach focuses on providing a new treatment option for post-surgical pain relief.

Why it matters

Potential benefit: If successful, this study could offer a new effective treatment for managing acute pain after bunion surgery.

How similar studies have gone: Other studies evaluating similar pain management approaches have shown promise, but the specific use of VX-993 in this context is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Key Inclusion Criteria:

Before Surgery:

* Participant scheduled to undergo a primary unilateral bunionectomy with distal first metatarsal osteotomy (i.e., Austin procedure) and internal fixation under regional anesthesia (Mayo block)

After Surgery:

* Participant is lucid and able to follow commands
* All analgesic guidelines were followed during and after the bunionectomy

Key Exclusion Criteria:

Before Surgery:

* Prior history of bunionectomy or other foot surgery on the index foot
* History of cardiac dysrhythmias requiring anti-arrhythmia treatment(s) within the last 2 years
* A known or clinically suspected active infection with human immunodeficiency virus or hepatitis B or C viruses

After Surgery:

* Participant had a Type 3 deformity requiring a base wedge osteotomy or concomitant surgery such as hammertoe repair, or had medical complications during the bunionectomy

Other protocol defined inclusion/exclusion criteria may apply.

Where it's running

  • Shoals Medical Trials Inc.
    Sheffield, Alabama, United States
    Recruiting
  • Trovare Clinical Research
    Bakersfield, California, United States
    Recruiting
  • Arizona Research Center
    Phoenix, Arizona, United States
    Completed
  • Woodland International Research Group
    Little Rock, Arkansas, United States
    Completed
  • New Hope Research Development | Tarzana, CA
    Tarzana, California, United States
    Completed
  • Clinical Pharmacology of Miami
    Miami, Florida, United States
    Completed
Show 8 more locations
  • ForCare Clinical Research
    Tampa, Florida, United States
    Completed
  • Atlanta Center for Medical Research
    Atlanta, Georgia, United States
    Completed
  • BioBehavioral Research of Austin
    Austin, Texas, United States
    Completed
  • HD Research LLC | First Surgical Hospital
    Bellaire, Texas, United States
    Completed
  • HD Research LLC | Legent Orthopedic Hospital
    Carrollton, Texas, United States
    Completed
  • Memorial Hermann Village
    Houston, Texas, United States
    Completed
  • Endeavor Clinical Trials
    San Antonio, Texas, United States
    Completed
  • JBR Clinical Research
    Salt Lake City, Utah, United States
    Completed

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.